In Fig 6A, HER2 (gene symbol ERBB2; probe 216836_at*) expression increased (Mann-Whitney test p-value = 0.079) in response to trastuzumab treatment in HER2-positive breast cancer. Here, ERBB2 is linked to breast carcinoma.